Psychometric Evaluation of the Borderline Personality Disorder Severity Index—IV—Adolescent Version and Parent Version

2012 ◽  
Vol 26 (4) ◽  
pp. 628-640 ◽  
Author(s):  
H. Marieke Schuppert ◽  
Josephine Bloo ◽  
Ruud B. Minderaa ◽  
Paul M. G. Emmelkamp ◽  
Maaike H. Nauta
2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Silvio Bellino ◽  
Paola Bozzatello ◽  
Camilla Rinaldi ◽  
Filippo Bogetto

Antipsychotics are recommended for the treatment of impulsive dyscontrol and cognitive perceptual symptoms of borderline personality disorder (BPD). Three reports supported the efficacy of oral risperidone on BPD psychopathology. Paliperidone ER is the metabolite of risperidone with a similar mechanism of action, and its osmotic release reduces plasmatic fluctuations and antidopaminergic effects. The aim of this study is to evaluate efficacy and safety of paliperidone ER in BPD patients. 18 outpatients with a DSM-IV-TR diagnosis of BPD were treated for 12 weeks with paliperidone ER (3–6 mg/day). They were assessed at baseline, week 4, and week 12, using the CGI-Severity item, the BPRS, the HDRS, the HARS, the SOFAS, the BPD Severity Index (BPDSI), and the Barratt Impulsiveness Scale (BIS-11). Adverse events were evaluated with the DOTES. Paliperidone ER was shown to be effective and well tolerated in reducing severity of global symptomatology and specific BPD symptoms, such as impulsive dyscontrol, anger, and cognitive-perceptual disturbances. Results need to be replicated in controlled trials.


2018 ◽  
Vol 32 (2) ◽  
pp. 207-219 ◽  
Author(s):  
Ester di Giacomo ◽  
Arnoud Arntz ◽  
Maria Fotiadou ◽  
Eugenio Aguglia ◽  
Lavinia Barone ◽  
...  

Borderline personality disorder (BPD) has a core embodied in affective and behavioral dysregulations, impulsivity, and relational disturbance. Clinical presentation might be heterogeneous due to a combination of different symptoms listed in the DSM-5. Clinical diagnosis and assessment of the severity of manifestations might be improved through the administration of structured interviews such as the Borderline Personality Disorder Severity Index, 4th edition (BPDSI-IV). The psychometric properties of the Italian version of the BPDSI-IV were examined for the first time in 248 patients affected by BPD and 113 patients affected by bipolar disorder, proving to be a valid and accurate instrument with good internal consistency and high accuracy. The Italian version also demonstrates significant validity in the discrimination between these clinical groups (p < 5001).


2012 ◽  
Vol 46 (6) ◽  
pp. 396-403 ◽  
Author(s):  
Christoph Kröger ◽  
Melanie Vonau ◽  
Sören Kliem ◽  
Stefan Roepke ◽  
Joachim Kosfelder ◽  
...  

2013 ◽  
Vol 203 (3) ◽  
pp. 163-164 ◽  
Author(s):  
Paul Moran ◽  
Mike J. Crawford

SummaryThe identification of a reliable and valid severity index for borderline personality disorder has vexed researchers for decades. A simple, clinically intuitive severity index for borderline personality disorder with predictive validity has now been identified. This index could usefully guide treatment planning, but other contextual factors should also determine the need for specialist treatment.


2009 ◽  
Vol 39 (12) ◽  
pp. 1967-1978 ◽  
Author(s):  
S. H. Aggen ◽  
M. C. Neale ◽  
E. Røysamb ◽  
T. Reichborn-Kjennerud ◽  
K. S. Kendler

BackgroundDespite its importance as a paradigmatic personality disorder, little is known about the measurement invariance of the DSM-IV borderline personality disorder (BPD) criteria; that is, whether the criteria assess the disorder equivalently across different groups.MethodBPD criteria were evaluated at interview in 2794 young adult Norwegian twins. Analyses, based on item-response modeling, were conducted to test for differential age and sex moderation of the individual BPD criteria characteristics given factor-level covariate effects.ResultsConfirmatory factor analytic results supported a unidimensional structure for the nine BPD criteria. Compared to males, females had a higher BPD factor mean, larger factor variance and there was a significant age by sex interaction on the factor mean. Strong differential sex and age by sex interaction effects were found for the ‘impulsivity’ criterion factor loading and threshold. Impulsivity related to the BPD factor poorly in young females but improved significantly in older females. Males reported more impulsivity compared to females and this difference increased with age. The ‘affective instability’ threshold was also moderated, with males reporting less than expected.ConclusionsThe results suggest the DSM-IV BPD ‘impulsivity’ and ‘affective instability’ criteria function differentially with respect to age and sex, with impulsivity being especially problematic. If verified, these findings have important implications for the interpretation of prior research with these criteria. These non-invariant age and sex effects may be identifying criteria-level expression features relevant to BPD nosology and etiology. Criterion functioning assessed using modern psychometric methods should be considered in the development of DSM-V.


2003 ◽  
Vol 17 (1) ◽  
pp. 45-59 ◽  
Author(s):  
Arnoud Arntz ◽  
Marije van den Hoorn ◽  
Jurgen Cornelis ◽  
Roel Verheul ◽  
Wies M.C. van den Bosch ◽  
...  

2009 ◽  
Vol 24 (2) ◽  
pp. 79-85 ◽  
Author(s):  
A.D.I. van Asselt ◽  
C.D. Dirksen ◽  
A. Arntz ◽  
J.H. Giesen-Bloo ◽  
J.L. Severens

AbstractIntroductionBorderline Personality Disorder (BPD) is a severe psychiatric disorder and is associated with significant impairment in quality of life. The aim of the present study is to assess the internal and external responsiveness of the EuroQoL-5D (EQ-5D) in BPD patients.Patients and MethodsData from 49 patients included in a multi-center Dutch randomized trial were used. We used both the EQ-5D utility score and the Visual Analogue Scale of the EuroQoL, and the Borderline Personality Disorder Severity Index-IV (BPDSI-IV). To determine internal responsiveness, we calculated the standardized response mean (SRM). To determine external responsiveness, we calculated Spearman correlations for the change scores, and compared EQ-5D scores for clinically improved vs. non-clinically improved patients as measured with the BPDSI-IV.ResultsPatient scores improved on all instruments during the three years. SRMs for BPDSI-IV were significantly higher than EQ-5D utility. Three-year Spearman correlation between change scores of BPDSI-IV and EQ-5D utility was 0.487, between BPDSI-IV and EQ-VAS it was 0.404, both statistically significant. EQ-5D utility scores for patients who clinically improved were significantly higher than for patients who did not.DiscussionWe conclude that the EQ-5D is fairly responsive in BPD, and, therefore, especially because of its brevity and user-friendliness, can serve as a useful tool in economic evaluations in patients with BPD.


Sign in / Sign up

Export Citation Format

Share Document